Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22226517

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2012 Jan 28
First author
Bang YJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Jan 28;379(9813):291-2. doi: 10.1016/S0140-6736(11)61928-4.
    note
    Source null
    related pmid
    22226518
    relationship
    Comment in

Authors and identifiers

  1. name
    Bang YJ
    type
    Author
  2. name
    Kim YW
    type
    Author
  3. name
    Yang HK
    type
    Author
  4. name
    Chung HC
    type
    Author
  5. name
    Park YK
    type
    Author
  6. name
    Lee KH
    type
    Author
  7. name
    Lee KW
    type
    Author
  8. name
    Kim YH
    type
    Author
  9. name
    Noh SI
    type
    Author
  10. name
    Cho JY
    type
    Author
  11. name
    Mok YJ
    type
    Author
  12. name
    Kim YH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bang YJ
    type
    Author
  2. name
    Kim YW
    type
    Author
  3. name
    Yang HK
    type
    Author
  4. name
    Chung HC
    type
    Author
  5. name
    Park YK
    type
    Author
  6. name
    Lee KH
    type
    Author
  7. name
    Lee KW
    type
    Author
  8. name
    Kim YH
    type
    Author
  9. name
    Noh SI
    type
    Author
  10. name
    Cho JY
    type
    Author
  11. name
    Mok YJ
    type
    Author
  12. name
    Kim YH
    type
    Author
bibliography ids
  1. nci-bib-4611e2e3a09d06c069caa6c0
book metadata
content sha256
7d972885706bd1ea8870c4cc9b863881bb48bdcd1a9b4677d22ed1aa8dbd9830
document type
citation
dois
  1. 10.1016/S0140-6736(11)61873-4
electronic publication date
display
2012 Jan 7
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22226517
immutable id
pubmed:22226517@7d972885706bd1ea8870c4cc9b863881bb48bdcd1a9b4677d22ed1aa8dbd9830
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9813
name
Lancet (London, England)
nlm unique id
2985213R
pages
315-21
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Jan 28;379(9813):291-2. doi: 10.1016/S0140-6736(11)61928-4.
    note
    Source null
    related pmid
    22226518
    relationship
    Comment in
outcomes validated
false
pmid
22226517
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
a1c93ad8e461ef4cd80e83590457ac4dd8173328e1062cd0b421093d8c726840
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 Jan 28
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22226517/
title
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Preserved source evidence · Not medical advice